FRANKFURT, April 7 – Evotec said on Tuesday it would continue a dialogue with investor MAK Capital, which has published a list of changes it wants the German biotech firm to make.
(Reporting by Tom SimsWriting by Ludwig BurgerEditing by Miranda Murray)
Comments